Sequence-specific 1H and 15N resonance assignments for human dihydrofolate reductase in solution.
Sequence-specific 1H and 15N resonance assignments for human dihydrofolate reductase in solution.
复制标题
溶液中人二氢叶酸还原酶的序列特异性 1H 和 15N 共振分配。
DOI:
10.1021/bi00116a031
复制
发表时间:
1992
期刊:
影响因子:
2.9
通讯作者:
Freisheim,JH
中科院分区:
文献类型:
--
作者:
Stockman,BJ;Nirmala,NR;Wagner,G;Delcamp,TJ;DeYarman,MT;Freisheim,JH
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, and Department of Biochemistry and Molecular Biology, Medical College of Ohio, Toledo, Ohio 43699 Received July 17, 1991; Revised Manuscript Received September 25, 1991 abstract: Dihydrofolate reductase is an intracellular target enzyme for folate antagonists, including the anticancer drug methotrexate. In order to design novel drugs with altered binding properties, a detailed description of protein-drug interactions in solution is desirable to understand the specificity of drug binding. As a first step in this process, heteronuclear three-dimensional NMR spectroscopy has been used to make sequential resonance assignments for more than 90% of the residues in human dihydrofolate reductase complexed with methotrexate. Uniform enrichment of the 21.5-kDa protein with 15N was required to obtain the resonance assignments via heteronuclear 3D NMR spectroscopy since homonuclear 2D spectra did not provide sufficient resonance dispersion. Medium-and long-range NOE’s have been used to characterize the secondary structure of the binary ligand-enzyme complex in solution.Dihydrofolate reductase (5, 6, 7, 8-tetrahydrofolate: NADP+ oxidoreductase, EC 1.5. 1.3) catalyzes the NADPH-dependent reduction of 7, 8-dihydrofolate to 5, 6, 7, 8-tetrahydrofolate. Tetrahydrofolate or its derivatives are essential cofactors in the biosynthesis of purine nucleotides, thymidylate, and several amino acids. Failure to maintain adequate levels of tetra-